That is essential, since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has been an experimental process (bleeding edge). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're developed to do. This was an advancement practically nobody noticed. But it's going to have profound implications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment opportunities in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (first lady). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back maybe considerably prior to going higher - biotech stock. I've been covering bitcoin for a long time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. But that's not the big question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. the legacy report predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are so numerous great private business on the brink of striking the public markets And I have actually been dealing with a new method for you to invest even prior to these business go public.
This chance has actually been building over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to book your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our normal beat (tech predictions). And when it concerns tech investing, we leave it to the specialists. Fortunately, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (jeff brown genetic sequencer stock). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and predict what's just around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing exponential development and developing incredible opportunities for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. biotech stocks. But despite what many readers might think, this is a pattern that's just getting started. Despite the fact that the COVID-19 pandemic disrupted supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (future report review). Losing 2 months of manufacturing and sales truly impacts how numerous 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million units is exceptional. More significantly, the delays triggered by the pandemic created a lots of suppressed need. Which need is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G gadgets will be delivered in 2021 - brownstone research stock. And that's not my only 5G forecast When I've talked about 5G in the past, I have actually described its 3 various phases.
In Phase 2, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Phase Three, 5G services begin to be provided (black sea). That's when we begin to see applications running on 5G networks. Think about things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase 3 by this summer season. This starts something of a virtuous cycle: Most people do not actually appreciate the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances moving forward will be enormous. Stepping far from 5G, the next essential technology I predict in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For many years, CRISPR was mostly a specific niche technology that wasn't well understood. And throughout that time, there were truly just 3 business operating in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire market is effectively a greenfield opportunity.
There's space for lots of business to exist in this area. biotech stocks. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can accurately forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That's important because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug therapies produced using this innovation. This was one of those developments that nearly nobody observed. But it's going to have extensive ramifications for curing disease. And, of course, there will be a lot of financial investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back maybe considerably prior to going greater. I've been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - korean actress. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. jeff brown top stock pick 2021. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details is up to date as of February 2021, however we might not separately validate this claim. Given Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to choose winning innovation stocks. He invested more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent perspective on the marketplace. He's constantly on the hunt for new chances, and he shares many of his best picks in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully predicted a few of the most significant economic occasions of the past 20 years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it right whenever, but Jeff Brown's accurate predictions have made him legions of dedicated fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a prominent financial research study publisher. Brownstone Research provides several research services with a wide range of expertises - future report.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - jeff brown 1 biotech. On its site, Brownstone states its objective is to provide retail investors with professional-grade research: "For too long, the very best financial investment research study has not been available to specific investors. It has been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth customers. self-driving cars. The objective of Brownstone Research is to make that sort of exclusive research study offered to any financiers aiming to acquire an edge in the marketplaces. The goal is basic to deliver distinct and successful financial investment research found no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown predictions for 2021. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown believes S.A.V. genetic sequencing companies jeff brown. might be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge technologies: expert system and electrical cars. Musk hopes the combination will help him establish the first fully-autonomous, self-driving vehicles ever. It's nothing except the vehicle industry's Holy Grail. As you know, electric lorries and self-driving vehicle stocks have actually been huge this year, however the Wall Street maker has approved buzz without much concrete result. In spite of an extreme increase in competitors over the previous couple of years, Brown still thinks Musk has the very best chance of putting it all together.
tech might be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Lorry, and it might be the future of transportation. Basically, this innovation would permit you to rent your vehicle as a self-governing, self-driving taxi when you're not using it. You merely leave the car and press a button on an app that informs the car to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant portion of the revenues. It sounds outrageous, however it might be closed than you believe.